IFNG, interferon gamma, 3458

N. diseases: 1519; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 Biomarker group BEFREE Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors. 26365188 2015
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 Biomarker group BEFREE In the future, a comprehensive study of TLR3, CXCR4 and IFNγ axis in primary breast tumors and corresponding healthy tissues will be crucial to further understanding of the cancer network. 23053995 2012
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 Biomarker group CTD_human Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients. 19446661 2009
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 AlteredExpression group LHGDN Triptolide inhibits interferon-gamma-induced programmed death-1-ligand 1 surface expression in breast cancer cells. 18572307 2008
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 GeneticVariation group LHGDN Functional IFNG polymorphism in intron 1 in association with an increased risk to promote sporadic breast cancer. 15900487 2005
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 AlteredExpression group BEFREE These results establish that DIM-induced IFNgamma expression in human breast tumor cells is mediated by activation of both JNK and p38 pathways, which is ultimately dependent on intracellular calcium signaling. 15735741 2005
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 AlteredExpression group LHGDN The up-regulation of human caspase-8 by interferon-gamma in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. 14993214 2004
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 Biomarker group BEFREE These findings indicate that TNF-alpha treatment in combination with IFN-gamma may provide a successful approach to overcome the cellular heterogeneity of advanced breast tumours. 9038615 1996